• Home
  • Contact Us
Urica Therapeutics
  • Investors & Media
    • Resources
  • Menu Menu
  • Investors & Media
    • Resources

Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop dotinurad in North America and Europe

Press Releases
May 10, 2021
Read more
https://uricatherapeutics.com/wp-content/uploads/2023/04/logo-new2.png 0 0 admin https://uricatherapeutics.com/wp-content/uploads/2023/04/logo-new2.png admin2021-05-10 17:44:152022-12-01 22:13:44Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop dotinurad in North America and Europe

Press Release Archives

  • June 2023 (1)
  • December 2022 (1)
  • October 2022 (1)
  • May 2022 (1)
  • May 2021 (1)

2023 URICA THERAPEUTICS. ALL RIGHTS RESERVED. PRIVACY POLICY
WEBSITE BY TIDAL MEDIA GROUP
Scroll to top